X

Analysis

DEEP FOCUS: Everything you need to know about Spotify (SPOT) stock

Spotify (NYSE: SPOT) stock has recovered 38% since late December when it touched a new 52-week low of $103. However,…

Abbvie’s oncology push makes it an attractive stock

Abbvie (NYSE: ABBV) is one of the worse performing pharma stocks in the trailing 12-month period. The stock has declined…

Top biotech stocks to be considered for investment this year

When the massive selloff battered Wall Street in the final months of 2018, biotechnology stocks were no exception. And, most…

Rating downgrade of Lam Research dampens recovery hopes; stock dips 4%

The recovery of Lam Research (LRCX) from last year’s lows had received a boost after the latest earnings report but…

IPO: Things to know as Crowdstrike makes a scintillating market debut

You have probably heard about Crowdstrike already. It has previously unraveled a few high-profile hack incidents, including tracing the 2016…

Top 5 tech M&A announcements so far in 2019

The technology sector is fast evolving with new start-ups offering innovative services popping up on a regular basis. While acquisitions…

Duluth Holdings to report loss in Q1 as margins remain under stress

Duluth Holdings (Nasdaq: DLTH), a retailer of casual wear and accessories, will be publishing financial results for the first quarter…

LightPath Technologies stock dips to 4-year low

LightPath Technologies (NASDAQ: LPTH) stock fell to a 4-year low of $0.94 on Monday as investors remained concerned about the…

These deals set a new paradigm for healthcare industry

After a busy 2018, the scale of merger and acquisition activity in the healthcare industry is expected to be high…

Facebook – Will the giant fall or not?

Facebook (NYSE: FB) is in the middle of a storm right now with anti-trust probes and even calls for a…